TransMedics Group, Inc. (TMDX)
Latest news, insights and market data
Market Data
AI Insights
Stifel has maintained a Hold rating on TransMedics Group (TMDX) but raised its price target to $80 from $75. This adjustment reflects confidence in the company's outlook, suggesting analysts see potential for growth without a strong buy signal. Keep an eye on how this influences investor sentiment.
Latest News
| Title | Published |
|---|---|
Stifel Maintains Hold on TransMedics Group, Raises Price Target to $80 Stifel analyst Tom Stephan maintains TransMedics Group (NASDAQ:TMDX) with a Hold and raises the price target from $75 to $80. | 1 day ago |
7 Health Care Stocks With Whale Alerts In Today's Session | 10 days ago |
TransMedics: Why I'm Still Bullish After The Collapse TransMedics (TMDX) faces decelerating revenue growth, margin pressure, and increased investment, yet maintains strong market share gains and competitive... | 10 days ago |
Will Analyst Focus on TransMedics’ OCS Platform and Financial Metrics Change TransMedics Group’s (TMDX) Narrative? Will Analyst Focus on TransMedics’ OCS Platform and Financial Metrics Change TransMedics Group’s (TMDX) Narrative? | 13 days ago |
TransMedics Group Inc (NASDAQ:TMDX): An Affordable Growth Play With Strong Fundamentals TransMedics Group (TMDX) fits an Affordable Growth strategy with strong 77% EPS growth, fair valuation below industry peers, and solid profitability. | 14 days ago |
TransMedics Group, Inc. (TMDX) Presents at 46th Annual William Blair Growth Stock Conference - Slideshow 2026-06-04. The following slide deck was published by TransMedics Group, Inc. | 15 days ago |
TransMedics (TMDX) Down 4.4% Since Last Earnings Report: Can It Rebound? TransMedics (TMDX) Down 4.4% Since Last Earnings Report: Can It Rebound? | 15 days ago |
Stifel Maintains Hold on TransMedics Group, Raises Price Target to $80
Stifel analyst Tom Stephan maintains TransMedics Group (NASDAQ:TMDX) with a Hold and raises the price target from $75 to $80.
7 Health Care Stocks With Whale Alerts In Today's Session
TransMedics: Why I'm Still Bullish After The Collapse
TransMedics (TMDX) faces decelerating revenue growth, margin pressure, and increased investment, yet maintains strong market share gains and competitive...
Will Analyst Focus on TransMedics’ OCS Platform and Financial Metrics Change TransMedics Group’s (TMDX) Narrative?
Will Analyst Focus on TransMedics’ OCS Platform and Financial Metrics Change TransMedics Group’s (TMDX) Narrative?
TransMedics Group Inc (NASDAQ:TMDX): An Affordable Growth Play With Strong Fundamentals
TransMedics Group (TMDX) fits an Affordable Growth strategy with strong 77% EPS growth, fair valuation below industry peers, and solid profitability.
TransMedics Group, Inc. (TMDX) Presents at 46th Annual William Blair Growth Stock Conference - Slideshow
2026-06-04. The following slide deck was published by TransMedics Group, Inc.
TransMedics (TMDX) Down 4.4% Since Last Earnings Report: Can It Rebound?
TransMedics (TMDX) Down 4.4% Since Last Earnings Report: Can It Rebound?